Kola, Ismail

Can the pharmaceutical industry reduce attrition rates?

Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery

Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare

Cited by 4,167

The State of Innovation in Drug Development

Kola, I. (2008) · Clinical Pharmacology & Therapeutics

Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare

Cited by 276

Phenotypic Characterization of an α4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse

Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience

Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research

Cited by 204

The corticotropin–release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis

Engler, D., Redei, E., & Kola, I. (1999) · Endocrine Reviews

Stress Responses and CortisolNeuropeptides and Animal Physiology

Cited by 79